Rohrmann Sabine, Linseisen Jakob, Vrieling Alina, Boffetta Paolo, Stolzenberg-Solomon Rachael Z, Lowenfels Albert B, Jensen Majken K, Overvad Kim, Olsen Anja, Tjonneland Anne, Boutron-Ruault Marie-Christine, Clavel-Chapelon Francoise, Fagherazzi G, Misirli Gesthimani, Lagiou Pagona, Trichopoulou Antonia, Kaaks Rudolf, Bergmann Manuela M, Boeing Heiner, Bingham Sheila, Khaw Kay-Tee, Allen Naomi, Roddam Andrew, Palli Domenico, Pala Valeria, Panico Salvatore, Tumino Rosario, Vineis Paolo, Peeters Petra H M, Hjartåker Anette, Lund Eiliv, Redondo Cornejo Ma Luisa, Agudo Antonio, Arriola Larraitz, Sánchez Maria-José, Tormo María-José, Barricarte Gurrea Aurelio, Lindkvist Björn, Manjer Jonas, Johansson Ingegerd, Ye Weimin, Slimani Nadia, Duell Eric J, Jenab Mazda, Michaud Dominique S, Mouw Traci, Riboli Elio, Bueno-de-Mesquita H Bas
Division of Clinical Epidemiology, German Cancer Research Centre, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Cancer Causes Control. 2009 Jul;20(5):785-94. doi: 10.1007/s10552-008-9293-8. Epub 2009 Jan 16.
To examine the association of baseline and lifetime ethanol intake with cancer of the pancreas in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Included in this analysis were 478,400 subjects, of whom detailed information on the intake of alcoholic beverages at baseline and over lifetime was collected between 1992 and 2000. During a median follow-up time of 8.9 years, 555 non-endocrine pancreatic cancer cases were observed. Multivariate Cox proportional hazard models were used to examine the association of ethanol intake at recruitment and average lifetime ethanol intake and pancreatic cancer adjusting for smoking, height, weight, and history of diabetes.
Overall, neither ethanol intake at recruitment (relative risk (RR) = 0.94, 95% confidence interval (CI) 0.69-1.27 comparing 30+ g/d vs. 0.1-4.9 g/d) nor average lifetime ethanol intake (RR = 0.95, 95% CI 0.65-1.39) was associated with pancreatic cancer risk. High lifetime ethanol intake from spirits/liquor at recruitment tended to be associated with a higher risk (RR = 1.40, 95% CI 0.93-2.10 comparing 10+ g/d vs. 0.1-4.9 g/d), but no associations were observed for wine and beer consumption.
These results suggest no association of alcohol consumption with the risk of pancreatic cancer.
在欧洲癌症与营养前瞻性调查(EPIC)中,研究基线乙醇摄入量和终生乙醇摄入量与胰腺癌之间的关联。
本分析纳入了478400名受试者,在1992年至2000年期间收集了他们关于基线时和终生酒精饮料摄入量的详细信息。在中位随访时间8.9年期间,观察到555例非内分泌性胰腺癌病例。使用多变量Cox比例风险模型,在调整吸烟、身高、体重和糖尿病史后,研究招募时的乙醇摄入量、平均终生乙醇摄入量与胰腺癌之间的关联。
总体而言,招募时的乙醇摄入量(相对风险(RR)=0.94,95%置信区间(CI)0.69-1.27,比较30+克/天与0.1-4.9克/天)和平均终生乙醇摄入量(RR = 0.95,95% CI 0.65-1.39)均与胰腺癌风险无关。招募时来自烈酒/白酒的高终生乙醇摄入量往往与较高风险相关(RR = 1.40,95% CI 0.93-2.10,比较10+克/天与0.1-4.9克/天),但未观察到葡萄酒和啤酒消费与胰腺癌风险之间的关联。
这些结果表明饮酒与胰腺癌风险无关。